Aeolus Pharmaceuticals, Inc.

Incara announces 1-for-10 reverse split and name change

Published in Lab Business Week, July 25th, 2004

Incara Pharmaceuticals Corp. (ICRA) announced that its board of directors has authorized and its majority shareholder has approved a 1-for-10 reverse split of its common stock as part of a program of planned internal changes designed to streamline the company.

The record date for the reverse split was July 6, 2004, and the common stock began trading on a split-adjusted basis on July 7, 2004. The effective date for the reverse split will be July 16, 2004. As a result of the reverse split, every 10 shares of common stock will be combined into 1 share of common stock. The reverse stock split affects all of the company's common stock, preferred stock, stock options, and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2004-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry